0.1860
-0.0460
(-19.83%)
At close: February 18 at 8:02:35 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
17,239.0000
17,239.0000
15,981.0000
765.0000
4,171.0000
Investing Cash Flow
-5,177.0000
-5,177.0000
-1,362.0000
-739.0000
1,184.0000
Financing Cash Flow
-3,523.0000
-3,523.0000
-1,834.0000
-3,524.0000
13,039.0000
End Cash Position
36,973.0000
36,973.0000
28,444.0000
15,694.0000
19,205.0000
Capital Expenditure
-5,177.0000
-5,177.0000
-1,362.0000
-739.0000
-1,092.0000
Issuance of Capital Stock
521.0000
521.0000
3.0000
40.0000
18,031.0000
Repayment of Debt
--
--
-294.0000
-45.0000
-1,361.0000
Free Cash Flow
12,062.0000
12,062.0000
14,619.0000
26.0000
3,079.0000
12/31/2020 - 6/24/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6XY.F HBM Holdings Limited
0.5950
+10.19%
PHPN.F Galectin Therapeutics Inc.
1.4200
+10.08%
HPHA.F Heidelberg Pharma AG
2.2900
-0.87%
EU6.F PDS Biotechnology Corporation
1.4950
+0.47%
AYJ.DE Valneva SE
3.5520
+5.28%
J90.F NurExone Biologic Inc.
0.3920
0.00%
ALTME.PA TME Pharma N.V.
0.0755
-2.20%
SEOVF Sernova Biotherapeutics Inc
0.1400
0.00%
0QF.DE Moderna, Inc.
34.59
+10.09%
CNTX Context Therapeutics Inc.
0.8300
+1.02%